DecisionBase

Empowering Decision Makers with Robust Interactive Data and Analysis

Drug development isn't what is used to be. Gone are the days of relying on blockbusters. Instead the drug industry is faced with identifying incremental drug improvements that will be commercially compelling.

In response to these changing times, Decision Resources has completely revamped its data and analysis tool, DecisionBase, to better address the needs of the industry. DecisionBase 2007 combines market forecasts with clinical and commercial endpoints to assess market share projections in 35 indications. These outputs are driven by quantitative and qualitative primary research.

DecisionBase 2007 provides detailed market share, patient share, and price-per-day projections for emerging drugs in development. The market share projections are based on prescriber surveys that compare physicians' expectations of a potential target product profile with an emerging product profile of the leading drugs in development. The forecast is built upon evaluation of commercial and clinical drivers that impact the market. In the commercial environment, we examine pricing, reimbursement, regulatory issues, and promotional activity. The clinical environment includes disease severity, current therapies, patient population, and quality of life measures.

Each indication assesses:

• Market forecast information including diagnosis rates, drug-treated, patient share, price-per-day, and compliance rates.
• Commercial information including pricing, reimbursement, labeling, and regulatory history.
• Clinical measurements including disease severity, current therapies, patient population, and quality of life measures.

Download our DecisionBase brochure

View 2008 DecisionBase report titles and indications